Article info
Hepatology
Original article
Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C
- Correspondence to Dr Yongfang Jiang, Liver Diseases Research Center The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, Hunan 410011, China; jiangyongfang@hotmail.com or Dr Rujun Gong, Department of Medicine, Rhode Island Hospital, Brown University School of Medicine, Middle House Suite 301, 593 Eddy Street, Providence, RI 02903, USA; Rujun_Gong{at}Brown.edu
Citation
Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C
Publication history
- Received September 9, 2013
- Revised March 28, 2014
- Accepted April 15, 2014
- First published May 8, 2014.
Online issue publication
December 08, 2014
Article Versions
- Previous version (8 May 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions